Bibliografía
1. Garlipp C R, Rossi C L & Bottini P V. Cerebrospinal fuid profiles in acquired immunodeficiency syndrome with ad without neurocriptococcosis. Rev. Inst. Med. Trop. S. Paulo 1997;39 n.6.
2. Katr RL, Alappattuc, Glass YP, Brunner YM: Cerebrospinal fluid manifestations of the neurologic complications of human immunodeficiency virus infection. Acta Cytol 1989; 33: 233-244,
3. Tan DB, Yong YK, Tan HY, et al: Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis. HIV Med. 2008; 9(5):307-16.
4. Mikdeshi J, Kennedy S, Krumholz A. Recurrent benign lymphocytic (Mollaret) meningitis in systemic lupus erythematosus. Neurologist. 2008 ;14(l):43-5.
5. Pearce JM. Mollaret`s meningitis. Eur Neurol. 2008;60(6):316-7.
6. Ito, U., Inaba Y, Cerebrospinal fluid cytology after subarachnoid hemorrhage. J Neurosurg. 1979; 51:352-354
7. Chamberlain MC. Carcinomatous meningitis. Arch Neurol 1997,54:16-17.
8. Boy le R, Thomas M, Adams JH. Diffuse involvement of the leptomeninges by tumour a clinical and pathological study of 63 cases. Postgrad Med J 1980;56:149-158.
9. Alicioglu B, Saynak M. Spinal leptomeningeal metástasis in a patient with squamous cell lung cáncer. Rev Port Pneumol. 2008;14(6):875-879.
10. Chamberlain MC.Neoplastic meningitis. Oncologist. 2008;13(9):967-77
11. Freilich,RJ, Krol. G, DeAngelis, L.M. Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metástasis. Ann Neurol. 1995;38(l):51-7.
12. Gajjar A, Fouladi M. , Walter A.W. et al: Comparison of lumbar and shunt Cerebrospinal Fluid Specimens for Cytologic Detection of Leptomeningeal Disease in Pediatric Patients with Brain Tumors. J. Clin. Oncol 1999; 17: 1825-1831
13. Packer RY, Seiegel KR, Sutton LN et al: Leptomeningeal dissemination of primary central nervous system tumors of childhood. Ann Neurol 1985 18: 217-221.
14. Chhieng DC, Elgert P, Cohén JM, et al: Cytology of primary central nervous system neoplasms in cerebrospinal fluid specimens. Diagn Cytopathol. 2002;26(4):209-12.
15. Gupta RK, Naran S, Lallu S, Fauck R. Cytodiagnosis of neoplasms of the central nervous system in cerebrospinal fluid samples w¡th an application of selective immunostains in differentiation. Cytopathology, 2004;15:38-43.
16. De Almeida S M, Nanakanishi E, de ContoA J et al: Cerebrospinal fluid cytological and biochemical characteristics in the presence of CNS neoplasia. Arq. Neuro-Psiquiatr. 2007; 65: 233-243.
17. Balhuizen J. C, Bots G. A. M, Schaberg A., et al: Value of cerebrospinal fluid cytology for the diagnosis of malignancies in the central nervous system. J Neurosurg. 1978; 48:747-753.
18. Glass JP, Melamed M, Chemik NL et al: Malignant cells in cerebrospinal fluid (CSF): The meaning of a positive CSF cytology. Neurology 1979;29:1369-1375
19. Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients. Cáncer 1982;49:759-772
20.- Twijnstra A, Ongerboer de Visser BW, van Zanten AP. Diagnosis of leptomeningeal metástasis. Clin. Neurol Neurosurg 1987: 89:79-85
21. Olson ME, Chermik NL, Posner JB: Infiltration of leptomeninges by systemic cancer: A clinical and pathological study. Arch Neurol 30:122-137, 1974.
22. Wasserstrom WR, Schwartz MK, Fleisher M et al. Cerebrospinal fluid biochemical markers in central nervous system tumors: A review. Ann Clin Lab Sci 1981;! 1:23 9-251.
23. Chamberlain MC. Cytologically negative carcinomatous meningitis: Usefulness of CSF biochemical markers. Neurology 1998;50:1173-1175.
24. Garson JA, Coakham HB, Kemshead JT et al: The role of monoclonal antibodies in brain tumour diagnosis and cerebrospinal fluid (CSF) cytology. J Neurooncol 1985 ;3:165-171.
25. Hovestadt A, Henzen-Logmans SC, Vecht CJ. Immunohistochemical analysis of the cerebrospinal fluid for carcinomatous and lymphomatous leptomeningitis. Br J Cáncer
1990;62:653-654.
26. Boogerd W, Vroom TM, van Heerde P et al: CSF cytology versus immunocytochemistry in meningeal carcinomatosis. J.Neurol Neurosurg Psychiatry 1988;51:142-145.
27. Edwars MS, Davis RL, Laurent JP. Tumor markers and cytologic features of cerebrospinal fluid. Cancer 1985;56. 1773-1777.
28. Watson CW, Hajdu: Cytology of primary neoplasms of the central nervous system. Acta Cytol 1997; 21: 40-47.
29. Miralbell R, Bieri S, Huguenin, P.et al: Prognostic value of cerebrospinal fluid cytology in pediatric medulloblastoma Ann of Oncol. 1999; 10: 239-241.
30. Fouladi M, Gajjar A, Boyett J M, et al: Comparison of CSF Cytology and Spinal Magnetic Resonance Imaging in the Detection of Leptomeningeal Disease in Pediatric Medulloblastoma or Primitive Neuroectodermal Tumor. J Clin Oncol, 1999; 17: 3234-3237.
31. Miller RR, Lin F, Mallonee MM. Cytologic Diagnosis ofGliomatosis Cerebri Acta Cytol 1981; 1:37-39
32. Cummings TY, Hulette CM, Longee DC. Et al: Gliomatosis Cerebri; cytologic and autopsy findings. Clin Neuropathol 1999; 4: 190-197
33. Kounar E, Kun L, Krischer J: Patterns of dissemination and recurrence of childhood ependimoma. Ann Neurol 1991, 30: 457-463.
34. GopaL P., Parker J. R., Debski R. et al: Choroid Plexus Carcinoma Arch Pathol Lab Med. 2008;132:1350-1354
35. Mitsuhashi, T, Shimizu Y, Ban S, et al: Anaplastic Oligodendroglioma Acta cytol. 2007; 51:657 – 660
36. ChamberJain MC. Neoplastic meningitis. J NeurooncoL 2005;75(l):71-83.
37. DeAngelis LM, Boutros D. Leptomeningeal metastasis. Cancer, Invest. 2005; 23: 145-54.
38. Chamberlain MC. Current concepts in leptomeningeal metastasis. Curr Opin Oncol. 1992;4:533-539.
39. Delord JP, Fizazi K, el Hajj M, Pautier P, Lhommé C. Isolated leptomeningeai metástasis from ovarian carcinoma: an unusual event. Eur J Cáncer. 1998;34(5):758-9.
40. Vadmal MS, Brones C, Farmer PM. Recurrent adenocarcinoma of the fallopian tube presenting as leptomeningeal carcinomatosis. Ann Clin Lab Sci. 1996;26(2):119-21.
41. Stein M, Steiner M, Ben-Schachar M, et al: Leptomeningeal involvement by epithelial ovarian carcinoma: a case report. Gynecol Oncol. 1987;27(2):241-5
42. Lee HG, Lee B, Kim SM, Suh BJ, Yu HJ. A case of gastric adenocarcinoma presenting as meningeal carcinomatosis. Korean J Intern Med. 2007; 22(4): 304-7.
43. Chang DT, Mancuso AA, Riggs CE Jr, Mendenhall WM. Merkel cell carcinoma of the skin with leptomeningeal metastases. Am J Otolaryngol. 2005;26(3):210-3.
44. Sugimori K, Kobayashi K, Hayashi M, et al: . Leptomeningeal carcinomatosis from urinary biadder adenocarcinoma: a clinic pathological case study. Neuropathology. 2005;25(1):89-94.
45. Chung P, Allerton R. Malignant meningitis secondary to ovarian carcinoma: an unusual occurrence. Clin Oncol. 2001; 13(2): 112-3.
46. Eggers SD, Salomao DR, Dinapoli RP, Vernino S. Paraneopiastic and metastatic neurologic complications of Merkel cell carcinoma. Mayo Clin Proc. 2001;76(3):327-30.
47. Chang DT, Mancuso AA, Riggs CE Jr. Mendenhall WN. Merkel cell carcinoma of the skin with leptomeningeal metastases. Semin NeuroL 2004 Dec;24(4): 363-74.
48. Mandell S, Wcmz J, Morales P et al: Carcinomatous meningitis from transitional cell carcinoma of bladder. Urology 1985; 25:520-1.
49. Bishop JR, Moul JW, Maldonado L et al. Transitional cell carcinomatous meningitis after M-VAC (Metholrexate, Vmblastine, Doxorubicin and Cisplatin) chemotherapy. Urology 1990;36:373-7.
50. Gordon AN, Kavanagh JJ, Wharton JT et al: Succesful treatment of leptomeningeal relapse of epithelial ovarian cancer. Gyn 0ncol 1984;18: 119-24.
51. Crino PB, Sater RA, Sperhng M et al: Renal cell carcinomatous meningitis: Pathologic and immunohistochemical features. Neurology 1995;45:189-91
52. Bigner SH, Johnston UW: The diagnostic challeng of tumors manifested iniatilly by the shedding of cells into cerebrospinal fluid. Acta Cytol 25:335-353, 1981.
53. Bigner SH: Cerebrospinal fluid cytology: current status and diagnostic application. J Neuropathol Exp Neurol 1992; 51: 235 -245.
54. Litíle JR, Dale AJ, Okazaki H. Meningeal carcinomatosis. Clinical manifestations. Arch Neurol 1974;30:13 8-143.
55. Shapiro WR, Posner JB, Ushio Y et al: Treatment of meningeal neoplasms. Cáncer Treat Rep 1977;61:733-743.
56. Rosen ST, Aisner J, Makuch RW et al: Carcinomatous leptomeningitis in small cell lung cáncer: A clinicopathologic review of the National Cáncer Institute experience. Medicine (Baltimore) 1982;61:45-53
57. Amer MH, Al SarrafM, Baker LH et al: Malignant melanoma and central nervous system metastases: Incidence, diagnosis, treatment and survival. Cáncer 1978;42:660-668
58. Yap HY, Yap BS, Tashima CK et al: Meningeal carcinomatosis in breast cáncer. Cáncer 1978;42:283-286.
59. Chamberlain MC, Kormanik P. Carcinoma meningitis secondary to non-small cell lung cáncer: Combined modality therapy. Arch Neurol 1998;55:506-512
60. Ano S, Satoh H, Nakazawa K, et al: Malignant Meningitis Secondary to Lung Adenocarcinoma: Int. Med. 2007;1749-1751
61. Nugent JL, Bunn PA Jr, Matthews MJ et al: CNS metastases in small cell bronchogenic carcinoma: Increasing frequency and changing pattem with lengthening survival. Cáncer 1979;44:1885-1893.
62. Balducci L, Little DD, Khansur T et al: Carcinomatous meningitis in small cell lung cancer. Am J Med Sci 1984; 287:31-3.
63. Alicioglu B, Saynak M. Spinal leptomeningeal metastasis in a patient with squamous cell lung cancer. Rev Port Pneumol. 2008;14(6):875-879.
64. Ignatius RT, Wills SM, Nadeau L, et al: Leptomeningeal carcinomatosis due to squamous cell carcinoma of the uterine cervix associated with HPV-45. J Clin Oncol. 2008 1;26(1):154-6.
65. Han L, Bhan R, Johnson S, et al: Leptomeningeal metastasis in a patient with squamous cell carcinoma of the uterine cervix: Report of a case and review of the literature. Diagn Cytopathol. 2007;35:660-2.
66 - Zhu JJ, Padillo O, DuffJ, et al: Cavernous sinus and leptomeningeal metastases arising from a squamous cell carcinoma of the face: case report. Neurosurgery. 2004;54(2):492-8.
67. Wang CJ, Wang CY. Nasopharyngeal carcinoma with leptomeningeal dissemination: case report. Chang Gung Med J. 2000;23(2):118-22.
68. Jayson GC, Howell A. Carcinomatous meningitis in solid tumors. Ann of Oncol 1996;7:773-86
69. Grossman SA, Moynihan TJ. Neurologic complications of systemic cancer Neoplastic meningitis. Neurol Clin 1991; 9: 843-56.
70. Fizazi K ,Asselain B, Vincent-Salomon A, et al: Meningeal Carcinomatosis in Patients with Breast Carcinoma. Cancer 1996; 77:1315-1323
71. Sorensen SC, Eagan RT, Scott M. Meningeal carcinomatosis in patients with primary breast or lung cáncer. Mayo Clin Proc 1984;59:91-94.
72. Chamberlain MC, Kormanik PR. Carcinomatous meningitis secondary to breast cáncer: Predictors of response to combined modality therapy. J Neurooncol 1997;35:55-64.
73. Ongcrboer de Visser BW, Somers R, Nooyen WH et al: Intraventricular methotrexate therapy of leptomeningeal metastasis from breast cancer. Neurology 1983; 33: 1565-72.
74. Jayson GC, Howell A, Hams M et al: Carcinomatous meningitis in breast cancer An aggressive disease variant. Cancer 1994;74:3135-41
75. Hams M, Howell A, Chrissohou M. A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer 1984; 50: 23-30.
76 . Smith DB, Howell A, Hams M. Carcinomatous meningitis associated with infiltrating lobular carcinoma of the breast. Eur J Surg Oncol 1985; 11: 33-6.
77. Delaunay N, Emy, A, Meraud, JP, et al: Melanomatous meningitis. Apropos of 3 cases Ann Dermatol Venerol. 1989;116:647-54.
78. Nicolson GL, Kawaguchi T, Kawaguchi M et al: Brain surface invasion and metastasis of murine malignant melanoma variants.
J Neurooncol 1987; 4: 209-18.
79. Kaplan JG, DeSouza TG, Farkash A et al: Leptomeningeal metastases: Comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol 1990;9:225-229.
80. Taní E, Costa I, Svedmyr E, Skoog L. Diagnosis of lymphoma, leukemia, and metastatic tumor involvement of the cerebrospinal fluid by cytology and immunocytochemistry. Diagn Cytopathol, 1995;12(l):14-22.
81. Chamberlain. MC, Nolan, C, Abrey LE. Leukemic and lymphomatous meningitis: incidence, prognosis and treatment. J Neurooncol. 2005;75(l):71-83.
82. Chamberlain MC, Nolan C, Abrey LE. 1 Leukemic and lymphomatous meningitis: incidence, prognosis and treatment. Cáncer Invest 2005; 23(2); 145-54.
83. Chamberlain MC, Nolan C, Abrey LE. Leukemic and lymphomatous meningitis: incidence, prognosis and treatment. J Neurooncol. 2005 ;75(l):71-83. Ann of Oncol 1999;10: 239-24.
84. Bleyer WA. Leptomeningeal cancer in leukaemia and solid tumors. Curr Probi Cancer 1988; 12:185-237.
85. Batchelor T, Loeffler JS. Primary CNS lymphoma. Clin Oncol. 2006; 24:1821-8.
86. Ekenel M, De Angelis LM. Treatment of primary Central nervous system lymphoma. Curr Neurol Neurosci Rep. 2007; 7(3):191-9.
87. Moriarty AT, Wiersemy L, Snider W, et al: Immunophenotyping of cytologic specimen by flow cytometry Diagn Cytopathol 1993; Q: 252 – 258.
88. Simir A, Fetsch P, Stetler-Stevenson M, Abati A Immunophenotypic analysis of non-Hodkin´s lymphomas in cytologic specimens. Diagn Cytopathol. 1999; 20:278-284.
89. Roddie P, Collie D and Johnson: Myelomatons involvement of the dura mater: a rare complication of multiple myeloma J Clin Pathol 2000;53:398-403.
90. Schluterman KO, Fassas AB, Van Hemer RL et al: Multiple Myeloma Invasion of the Central Nervous System.
Arch Neural 2004; 61: 1423-1429.
91. Cavanna L, Invernizzi R, Berte R, et al: Meningeal Involvement in Multiple Myeloma. Acta Cytol 1996;40:571-575
92. Schulman P, Sun T, Sharer L, et al: Meningeal involvement in IgD mieloma with cerebrospinal fluid protein analysis. Cancer 1980: 1213-1216.
93. Kramer W. Plasmacytome of the brain in Khaler’s disease Cancer 1982; 49: 1710-1712
94. Rostagno C., Felici M., Olivo G, et al: Meningeal carcinomatosis from pulmonary adenocarcinoma . Ann Ital Med Int 1995;1:253-256.
95. Hammerer V: Diagnosis and treatment of carcinomatous meningitis in lung cáncer. Rev Mal Respir 2007;24:222-225.
|